Firstly, such tumors are the hallmark of CRCs arising in the context of Lynch syndrome, resulting from a germline mutation in one of the MMR genes, most commonly MLH1 or MSH2, and young age at cancer diagnosis is regarded as an indicator for a possible hereditary cause of the disease. The gene discussed is MLH1; the disease is Lynch syndrome.